Clinical Trial Update: Sulindac and Breast Density in Women at Risk of Developing Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sulindac for changes in breast density in women at risk of developing breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sulindac (sulindac)

Snippet

Sponsor: Alison Stopeck | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED